MBMoo Jun Baek

Moo Jun Baek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Moo Jun Baek has a total of 111 co-authors. Here are the top co-authors by number of shared publications:

  • Moon Soo Lee

    Department of Surgery, College of Medicine, Soonchunhyang University, Chungcheongnam-do, 330-723, Korea

    12 shared publications
  • Tae Sung Ahn

    Department of Surgery, College of Medicine, Soonchunhyang University Cheonan Hospital, Cheonan 31151, Republic of Korea

    10 shared publications
  • Dongjun Jeong

    Department of Pathology, College of Medicine, Soonchunhyang University Cheonan Hospital, Cheonan 31151, Republic of Korea

    9 shared publications
  • Taesung Ahn

    Department of Colorectal Surgery, College of Medicine, Soonchunhyang University Cheonan Hospital, Cheonan 31151, Republic of Korea

    9 shared publications
  • Dong Hyun Kang

    Department of Surgery, College of Medicine, Soonchunhyang University Cheonan Hospital, Cheonan 31151, Republic of Korea

    6 shared publications
  • Dongjun Jeong

    Department of Pathology, College of Medicine, Soonchunhyang University, 31 Soonchunhyang 6 gil, Dongnam-gu, Cheonan 31151, Chungcheongnam-do, Republic of Korea

    6 shared publications

Latest Publications

  • Open Access

    Mechanistic Insights into Radiation Resistance in Colorectal Cancer: Gene Exploration Study

    by Beamjun Park, Soohyeon Lee, Inyoung Jo, Donghyun Kang, Taewan Kim, Jaesung Ryu, Hyejeong Kong, Moojun Baek, Taesung Ahn

    Radiotherapy is a cornerstone of colorectal cancer (CRC) treatment; however, its therapeutic efficacy is often compromised by both intrinsic and acquired resistance in CRC cells. This study employed small interfering RNA (siRNA) technology to elucidate the functional roles of BAMBI, GADD34, NFKBIA, and NFKBID in CRC cell lines SW480 and HCT116. We assessed their impact on key cellular processes and radiation sensitivity. Gene silencing of all four target genes significantly suppressed CRC cell proliferation, migration, and invasion. Moreover, siRNA-mediated knockdown enhanced radiation sensitivity, as evidenced by a substantial increase in apoptosis and a marked reduction in cell viability compared with controls. These findings suggest that BAMBI, GADD34, NFKBIA, and NFKBID serve as critical regulators of CRC progression and radiation resistance. Overall, this study provides a mechanistic foundation for further exploration into the pathways underlying radiation resistance and underscores the potential for developing personalized radiotherapy strategies guided by molecular profiling.


  • Open Access

    CYP4X1 Expression Is Associated with Metastasis and Poor Prognosis in Patients with Colorectal Cancer

    by Sooyoun Kim, Hakchun Kim, Inpyo Hong, Minho Lee, Hyeongjoo Kim, Hyoungjong Kwak, Chang-Jin Kim, Donghyun Kang, Taesung Ahn, Moojun Baek, et al.

    Globally, the mortality rate of colorectal cancer (CRC) remains high. Despite the development of various treatments, such as targeted therapy and immunotherapy, colorectal cancer continues to be a serious health issue worldwide. Identifying new biomarkers is essential for improving prognosis and tailoring targeted therapies for CRC. This study aims to elucidate the role of CYP4X1 in CRC and its association with patient survival and clinicopathological parameters. Using TCGA databases like GENT2, UALCAN, and GEPIA, we analyzed CYP4X1 expression in CRC and normal tissues. Our analysis revealed a significant increase in CYP4X1 expression in CRC tissues compared to normal tissues. And CYP4X1 high expression was strongly associated with advanced TNM stage, poor tumor differentiation, deeper invasion, and lymph node metastasis. Kaplan–Meier analysis revealed that high CYP4X1 expression correlated with shorter survival times. To investigate the relationship between CYP4X1 expression and colon cancer, WST-1, Transwell, and colony formation assays were performed using colon cancer cells with siRNA-mediated CYP4X1 downregulation. CYP4X1 downregulation significantly inhibited cell proliferation, invasion, migration, and colony formation in vitro. Furthermore, the tumor-forming ability in mice injected with cell lines where CYP4X1 expression was suppressed decreased. In conclusion, CYP4X1 overexpression is closely linked to CRC progression as an independent prognostic marker and potential therapeutic target.


  • Open Access

    TM7SF2 as a Potential Biomarker in Colorectal Cancer: Implications for Metastasis

    by Inpyo Hong, Sooyoun Kim, Minho Lee, Seoin Han, Hak Chun Kim, Chong Woo Chu, Seong Geun Kim, Min Kyung Kim, Chang Jin Kim, Dong Hyun Kang, et al.

    Colorectal cancer (CRC) is a commonly fatal cancer and ranks as the fourth most prevalent in men and third in women worldwide. While early-stage survival rates are high, they significantly decrease with recurrence and metastasis. Thus, the early detection and treatment of metastasis-related factors can significantly improve survival rates. In this study, the transmembrane 7 superfamily member 2 (TM7SF2) gene was validated as a biomarker for predicting metastasis in CRC. Immunohistochemical staining was performed on 236 CRC tissues, and the clinicopathological factors of patients with CRC were analyzed. This evaluation revealed that TM7SF2 expression is associated with the clinical stage. Kaplan–Meier analysis confirmed the relationship between the survival rate of CRC patients and TM7SF2 expression, showing a decrease in survival rate with TM7SF2 overexpression (log-rank, p < 0.001). TM7SF2 expression was also confirmed in two pairs of primary and metastatic cell lines (SW480 and SW620). TM7SF2 knockdown was executed using siRNAs in SW480 and SW620 cells, which exhibit high expression levels. The knockdown was verified using RT-PCR and immunoblotting. Functional studies investigated the effects of TM7SF2 on cell proliferation, migration, invasion, and colony formation, revealing that all these functions were suppressed in the CRC cell lines following TM7SF2 knockdown. Therefore, TM7SF2 shows promise as a biomarker for the prevention of colorectal cancer.

  • Open Access

    High Expression of Tetraspanin 5 as a Prognostic Marker of Colorectal Cancer

    by Sanghyun Roh, Sooyoun Kim, Inpyo Hong, Minho Lee, Han Jo Kim, Tae Sung Ahn, Dong Hyun Kang, Moo-Jun Baek, Hyoung Jong Kwak, Chang-Jin Kim, et al.

    Cancer is a major disease and the leading cause of death worldwide, with colorectal cancer (CRC) being the third-most common cancer in Korea. The survival rate associated with CRC reduces as the disease stage increases. Therefore, its early detection and treatment can greatly increase patient survival rates. In this study, we identified the tetraspanin 5 (TSPAN5) gene as an important biomarker for predicting the prognosis of patients with CRC. A TMA slide was used for statistical analysis. pN and clinical stage were found to be significant factors according to chi-square analysis, whereas pT, pN, metastasis, clinical stage, and TSPAN5 expression were significant according to Cox regression analysis. In order to prove the usefulness of TSPAN5, which is overexpressed in patients with metastatic CRC, as a biomarker, proliferation, migration, invasion, and tumorigenicity were examined using cell lines inhibited using small interfering RNA. The evaluations confirmed that TSPAN5 suppression, in turn, suppressed proliferation, migration, invasion, and tumorigenesis, which are characteristic of cancer cells. Therefore, the evaluation of TSPAN5 expression may help observe the prognosis of CRC and determine an appropriate treatment method for patients with CRC.


  • Open Access

    Expression of Spermine Oxidase Is Associated with Colorectal Carcinogenesis and Prognosis of Patients

    by Sooyoun Kim, Doyeon Kim, Sanghyun Roh, Inpyo Hong, Hyeongjoo Kim, Tae Sung Ahn, Dong Hyun Kang, Moon Soo Lee, Moo-Jun Baek, Hyoung Jong Kwak, et al.

    Uncovering tumor markers of colorectal cancer is important for the early detection and prognosis of the patients. Spermine oxidase (SMOX) is upregulated in various cancers. The present study aims to explore the biologic function and expression patterns of SMOX in colorectal cancer (CRC), the third most common type of cancer worldwide. We used quantitative real-time PCR, Western blot, and in vitro functional studies in four CRC cell lines knocked down by SMOX siRNA and immunohistochemistry in 350 cases of CRC tissues. The results showed that SMOX was overexpressed in CRC cell lines and clinical samples. SMOX overexpression in tumor tissues was an independent prognostic factor, worsening overall survival (p = 0.001). The knock-down of SMOX inhibited CRC cell proliferation, invasion, and soft agar colony formation, uncovering its carcinogenic functions. This study indicated that SMOX overexpression could be an important oncogene in CRC and might serve as a valuable prognostic marker and potential therapeutic target for CRC.


  • Intracellular delivery of oxaliplatin conjugate via cell penetrating peptide for the treatment of colorectal carcinoma in vitro and in vivo

    by Tejinder Singh, Dong Hyun Kang, Tae Wan Kim, Hye Jeong Kong, Jae Sung Ryu, Seob Jeon, Tae Sung Ahn, Dongjun Jeong, Moo Jun Baek, Jungkyun Im


  • Open Access

    Prognostic Relevance of HJURP Expression in Patients with Surgically Resected Colorectal Cancer

    by Dong Hyun Kang, Jongsoo Woo, Hyeongjoo Kim, Soo Youn Kim, Sanghee Ji, Gunn Jaygal, Tae Sung Ahn, Han Jo Kim, Hyoung Jong Kwak, Chang-Jin Kim, et al.

    HJURP is a key factor for CENP-A deposition and maintenance in centromeres. The role of mis-regulation of histone chaperones in cancer initiation and progression has been studied. However, its role in colorectal cancer is still unclear. In this study, we aimed to evaluate the expression of HJURP in 162 colorectal cancer tissue. To investigate the function of HJURP in the colorectal cancer cell, we suppressed HJURP expression by siRNA and confirmed proliferation, migration, invasion, and anchorage independent of colony forming ability. The association between HJURP expression levels and clinicopathological factors was evaluated in 162 CRC tissues using immunohistochemistry. The overall survival rate in patients of HJURP high expression was higher than those in HJURP low expression in CRC. Suppressing HJURP expression decreased cellular proliferation, invasion, and migration in four CRC cell lines: HT29, HCT116, SW480, SW620 in vitro study. Our findings revealed that the knockdown of HJURP suppressed the proliferation, migration, invasion, and tumorigenicity in CRC cells. Due to its strong association with CRC, HJURP could be a potential prognostic biomarker and a novel target for drug discovery.


  • Defensin alpha 6 (DEFA6) is a prognostic marker in colorectal cancer

    by Dongjun Jeong, Hyeongjoo Kim, Doyeon Kim, Seona Ban, Seunghyun Oh, Sanghee Ji, DongHyun Kang, Hyunyong Lee, Tae Sung Ahn, Han Jo Kim, et al.

    Defensin alpha 6 (DEFA6) is a member of the alpha defensin family of microbicidal and cytotoxic peptides that defend against bacteria and viruses. Here, we provide a novel function of DEFA6 in tumorigenesis of colorectal cancer (CRC) in vitro and in


  • Protein kinase, membrane‑associated tyrosine/threonine�1 is associated with the progression of colorectal cancer

    by Dongjun Jeong, Hyeongjoo Kim, Doyeon Kim, Seona Ban, Seunghyun Oh, Sanghee Ji, Donghuyn Kang, Hyunyong Lee, Tae Sung Ahn, Han Jo Kim, et al.

    The protein kinase, membrane-associated tyrosine/threonine 1 (PKMYT1) is known to inhibit precocious entry into mitosis by phosphorylating CDK1 at Thr14 and Tyr15 residues. However, the functional importance of PKMYT1 in colorectal cancer (CRC) remains unknown. Thus, it is important to elucidate whether PKYMT1 is indispensable in the tumorigenesis of CRC. To investigate the functional importance of PKMYT1 in CRC tumorigenesis, PKMYT1 was knocked down in CRC cell lines such as SW480, SW620, HCT116 and HT29 by siRNA. PKMYT1-depleted CRC cells were analyzed to determine proliferation, migration, invasion and colony forming ability. In addition, 179 patient-derived samples were used to find the correlation of the expression of PKMYT1 with the prognosis of CRC patients. By siRNA-mediated loss of function of PKMYT1, we observed that proliferation, migration, invasion and colony forming ability of CRC cell lines were significantly impaired in the absence of PKMYT1 in vitro. Furthermore, by analyzing patient-derived samples, we revealed the association of PKMYT1 with the overall survival rate of CRC patients. These results indicated that PKMYT1 plays an essential oncogenic role in CRC and could serve as a good therapeutic target for the treatment of CRC.


  • Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: A promising in vivo drug delivery system for colorectal cancer therapy

    by Chang-Seuk Lee, Hyungjoo Kim, Joonhee Yu, Su Hwan Yu, Seona Ban, Seunghyun Oh, Dongjun Jeong, Jungkyun Im, Moo Jun Baek, Tae Hyun Kim